ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 255105 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 255105; 2) Community: the network communities that were significantly associated with the response to NSC 255105; 3) Molecule: the relationships between components within communities and NSC 255105; 4) MDR: the compounds that were significantly associated with the NSC 255105.

NSC Compound Enrichment Correlation
NSC 677942 L-Glutamamide, N(2)-[4-[[(2,4-diamino-6-pteridinyl)methyl](methyl)amino]benzoyl]-N(1),N(5)-didecyl- 0.0382675857669587 0.38277127
NSC 682582 Null 0.0382675857669587 -0.30136973
NSC 683564 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, methyl ester, (Z,E)- 0.0382675857669587 0.69054898
NSC 687011 stereoisomer of 672120 (MW=262) 0.0382675857669587 0.63152779
NSC 673095 Null 0.0382675857669588 0.17963599
NSC 683557 Camptothecin Derivative 0.0382675857669588 0.092882223
NSC 700269 1,3-Dioxolo[4,5-g]quinolin-8(5H)-thione, 6-(2-fluorophenyl)- 0.0382675857669588 -0.0045245966
NSC 13318 Null 0.0414190425892865 0.47108547
NSC 179187 Salasdine 0.0414190425892865 -0.15568623
NSC 255104 Des-O-methylgeldanamycin 0.0414190425892865 0.69784847
Total:61  Current:49    [First] [Prev] [Next] [Last]